Screener
Dyne Therapeutics, Inc. DYN Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Operating expenses: | ||
| Research and development | $100,889 | $106,447 |
| General and administrative | 24,387 | 15,925 |
| Total operating expenses | 125,276 | 122,372 |
| Loss from operations | (125,276) | (122,372) |
| Other income (expense): | ||
| Interest income | 8,757 | 7,100 |
| Interest expense | (4,202) | — |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s total operating expenses?
- Dyne Therapeutics, Inc. (DYN) reported total operating expenses of $125.28M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Dyne Therapeutics, Inc.'s total operating expenses increased by 2.4% year-over-year, from $122.37M to $125.28M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s total operating expenses has grown at a 32.9% compound annual growth rate (CAGR), from $150.03M to $468.18M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Dyne Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude